Skip to main content
. 2022 Feb 1;29:101222. doi: 10.1016/j.bbrep.2022.101222

Fig. 2.

Fig. 2

Effects of caspase inhibitor on ecto-CRT accumulation in L-OHP-treated HT-29 cells. (A) HT-29 cells were treated with L-OHP (20 μM) for 4 or 48 h in the presence or absence of a caspase 3 inhibitor (Ac-DEVD-CHO) (100 μM), and CRT accumulation on the cells was measured. (B) HT-29 cells were treated with L-OHP (20 μM) for 4 h in the presence or absence of the caspase 12 inhibitor (Z-ATAD-FMK) (5 μM), and CRT accumulation on the cells was measured. The data are expressed as percentages of the values for untreated control HT29 cells. The data are presented as mean ± S.D. (n = 3) and differences between two groups were compared (*p<0.05; two-tailed non-paired Student's t-test).